63 min listen
Ep5: Psychedelic Science with Chris Witowski from Psilera
FromBIOACTIVE
ratings:
Length:
63 minutes
Released:
Aug 7, 2023
Format:
Podcast episode
Description
NOTHING DISCUSSED IN THIS PODCAST IS MEDCAL ADVICE
In this weeks episode of Bioactive Riley (@cannabichem) talks with Chris Witowski the CEO and cofounder of the biotech company Psilera investigating new psychedelic substances for the treatment of conditions like anxiety, depression, and PTSD.
Chris discusses the general pipeline for how Psilera goes about investigating new drug candidates as well as the advantages to non-hallucinogenic psychedelic drugs.
Thanks for listening and subscribing to this channel- mad love
Reach Chris and the rest of the Psilera team at:
info@psilera.com
twitter: @Psilera
IG: @Psilera
Papers discussed in this episode:
"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB" https://www.nature.com/articles/s4159...
Thank you to our podcast sponsor Boveda, and check out humidity packs for your cannabis at https://bovedainc.com/
In this weeks episode of Bioactive Riley (@cannabichem) talks with Chris Witowski the CEO and cofounder of the biotech company Psilera investigating new psychedelic substances for the treatment of conditions like anxiety, depression, and PTSD.
Chris discusses the general pipeline for how Psilera goes about investigating new drug candidates as well as the advantages to non-hallucinogenic psychedelic drugs.
Thanks for listening and subscribing to this channel- mad love
Reach Chris and the rest of the Psilera team at:
info@psilera.com
twitter: @Psilera
IG: @Psilera
Papers discussed in this episode:
"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB" https://www.nature.com/articles/s4159...
Thank you to our podcast sponsor Boveda, and check out humidity packs for your cannabis at https://bovedainc.com/
Released:
Aug 7, 2023
Format:
Podcast episode
Titles in the series (35)
Ep5: Psychedelic Science with Chris Witowski from Psilera by BIOACTIVE